|
FAM118B expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.684300E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.863500E-03 |
| Normal-vs-Stage2 |
8.493600E-02 |
| Normal-vs-Stage3 |
2.123400E-01 |
| Normal-vs-Stage4 |
6.986800E-01 |
| Stage1-vs-Stage2 |
8.217600E-01 |
| Stage1-vs-Stage3 |
1.244770E-01 |
| Stage1-vs-Stage4 |
9.218000E-03 |
| Stage2-vs-Stage3 |
4.021200E-01 |
| Stage2-vs-Stage4 |
7.015700E-02 |
| Stage3-vs-Stage4 |
1.630010E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.431700E-02 |
| Normal-vs-AfricanAmerican |
5.657900E-02 |
| Normal-vs-Asian |
7.361800E-02 |
| Caucasian-vs-AfricanAmerican |
5.904400E-01 |
| Caucasian-vs-Asian |
5.901000E-01 |
| AfricanAmerican-vs-Asian |
9.203400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.574800E-01 |
| Normal-vs-Female |
5.882500E-03 |
| Male-vs-Female |
8.333600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.538730E-03 |
| Normal-vs-Age(41-60Yrs) |
1.272030E-01 |
| Normal-vs-Age(61-80Yrs) |
3.999600E-01 |
| Normal-vs-Age(81-100Yrs) |
5.978800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.591900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.439700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.338760E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.175600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.190800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.621400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.628800E-01 |
| Classical-VS-Follicular |
2.720400E-01 |
| Classical-VS-Other |
3.068800E-01 |
| Classical-VS-Normal |
4.202400E-03 |
| Tall-VS-Follicular |
9.423400E-01 |
| Tall-VS-Other |
5.708600E-01 |
| Tall-VS-Normal |
3.188000E-01 |
| Follicular-VS-Other |
6.303800E-01 |
| Follicular-VS-Normal |
2.652400E-01 |
| Other-VS-Normal |
9.405200E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.102500E-02 |
| Normal-vs-N1 |
9.720400E-01 |
| N0-vs-N1 |
1.219010E-01 |
|
|
